An international, multicenter post hoc analysis comparing in-person and virtual medication management strategies in post-ICU recovery clinics.

Autor:	Beaudrie-Nunn AN; Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, TN, USA., Poyant JO; Department of Pharmacy, Tufts Medical Center, Boston, MA, USA., Groth CM; Department of Pharmacy, University of Rochester Medical Center, Rochester, NY, USA., Rappaport SH; Department of Pharmacy, University of Rochester Medical Center, Rochester, NY, USA., Kruer RM; Department of Pharmacy, Indiana University Health, Adult Academic Health Center, Indianapolis, IN, USA., Miller E; Department of Pharmacy, Indiana University Health, Adult Academic Health Center, Indianapolis, IN, USA., Whitten JA; Department of Pharmacy, Eskenazi Health, Indianapolis, IN, USA., Mcintire AM; Department of Pharmacy, Eskenazi Health, Indianapolis, IN, USA., McDaniel CM; Department of Pharmacy, Thomas Jefferson University Hospital, Philadelphia, PA, USA., Betthauser KD; Department of Pharmacy Services, Barnes-Jewish Hospital, St. Louis, MO, USA., Mohammad RA; Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA., Kenes MT; Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA., Bookstavar Korona R; Department of Pharmacy, Atrium Health Wake Forest Baptist, Winston-Salem, NC, USA., Barber AE; Department of Pharmacy, Atrium Health Wake Forest Baptist, Winston-Salem, NC, USA., MacTavish P; Pharmacy Department, Glasgow Royal Infirmary, Glasgow, Scotland., Dixit D; Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, and Robert Wood Johnson University Hospital, New Brunswick, NJ, USA., Yeung SYA; Department of Pharmacy Services, University of Maryland Medical Center, Baltimore, MD, USA., Stollings JL; Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, TN, and Critical Illness, Brain Dysfunction, and Survivorship (CIBS) Center, Nashville, TN, USA.
Jazyk:	angličtina
Zdroj:	American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2024 Aug 20. Date of Electronic Publication: 2024 Aug 20.
DOI:	10.1093/ajhp/zxae244
Abstrakt:	Disclaimer: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Purpose: To compare the incidence of ICU pharmacist interventions in intensive care unit recovery center (ICU-RC) in-person and virtual clinic visits. Methods: This was a post hoc analysis of interventions implemented by ICU pharmacists among adult patients who were referred to 12 ICU-RCs across the United States and the United Kingdom between September 2019 and July 2021, as reported in a previously published study "An International, Multicenter Evaluation of Comprehensive Medication Management by Pharmacists in ICU Recovery Centers." That study included patients who received a comprehensive medication review by an ICU pharmacist. Medication-related interventions performed by an ICU pharmacist during ICU-RC in-person clinic visits were compared to those performed during virtual clinic visits. Results: There were 507 patients referred to an ICU-RC, of whom 474 patients attended a clinic visit. Of those, 472 received a comprehensive medication review, with 313 patients attending in-person visits and 159 patients attending virtual visits. The incidence of medication-related interventions implemented was higher in the ICU-RC in-person clinic group compared to the virtual clinic group (86.5% vs 79.2%, P = 0.04). There was no difference in the median number of ICU pharmacist interventions per patient between the in-person and virtual clinic groups (2 vs 2, P = 0.13). An ICU admission diagnosis was an independent predictor of medication-related interventions among all patients. Conclusion: The incidence of ICU pharmacist interventions was higher at ICU-RC in-person clinic visits compared to virtual clinic visits. Pharmacists aid in meeting the complex pharmacologic challenges of post-intensive care syndrome in both settings. (© American Society of Health-System Pharmacists 2024. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu